-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Except for a few single-gene variants that account for less than 15% of cases, the exact factors that underpin the development of the neurodegenerative disease amyotrophic lateral sclerosis (ALS) remain unclear
Many epidemiological studies have considered the role of metabolic factors in the development of ALS
Some people think that strenuous exercise is more targeted and may be causally related to the susceptibility to ALS
Mendelian randomization studies also provide some evidence of a causal relationship between lipid biomarker levels and ALS
Most epidemiological studies of ALS are based on case-control studies.
In this way, Alexander G Thompson and others of the University of Oxford used data from the UK biobank to explore the relationship between metabolic factors, including lipid and carbohydrate metabolism markers in the blood, physical exercise and BMI, and the subsequent development of ALS.
Higher total cholesterol: High-density lipoprotein is associated with an increased risk of ALS ( HR 1.
Higher total cholesterol: High-density lipoprotein is associated with an increased risk of ALS (
In a model that combines multiple metabolic markers, in addition to a higher risk of high-density lipoprotein or lipoprotein A, higher low-density lipoprotein or lipoprotein B is associated with an increased risk of ALS
Coronary artery disease, cerebrovascular disease and aging are also associated with an increased risk of ALS
They found that the association of HDL, apoA1, and LDL levels with the risk of ALS contributes to growing evidence that pre-disease metabolic conditions may play a role in pathogenesis
The association of HDL, apoA1, and LDL levels with ALS risk contributes to growing evidence that pre-disease metabolic conditions may play a role in pathogenesis
Leave a message here
